Indicators of immunogenicity of influenza vaccine in HIV-infected patients seronegative to influenza virus
- Autores: Yapparov R.G.1, Lioznov D.A.2,3, Karnaukhova E.Y.3, Galankin T.L.3, Antonova T.V.3
-
Afiliações:
- Republican center for prevention and control of AIDS and infectious diseases
- Research Institute of Influenza
- Pavlov First State Medical University
- Edição: Nº 2 (2018)
- Páginas: 83-88
- Seção: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/279309
- ID: 279309
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Palavras-chave
Texto integral
Sobre autores
Rafael’ Yapparov
Republican center for prevention and control of AIDS and infectious diseases
Email: rafdok@yandex.ru
chief doctor, infectiologist
Dmitry Lioznov
Research Institute of Influenza; Pavlov First State Medical University
Email: dlioznov@yandex.ru
MD, deputy director for science; head of the Department Of infectious diseases and epidemiology
Elena Karnaukhova
Pavlov First State Medical University
Email: elena_yk@list.ru
PhD, assistant professor of the Department of infectious diseases and epidemiology
Timofey Galankin
Pavlov First State Medical University
Email: galankint@gmail.com
PhD, head of the laboratory of pharmacoepidemiology and pharmacocinetics
Tamara Antonova
Pavlov First State Medical University
Email: antonovatv28@yandex.ru
MD, professor, professor of the Department of knfectious diseases and epidemiology
Bibliografia
- Методические рекомендации по диагностике и лечению гриппа. Министерство здравоохранения Российской Федерации. Москва, 2016. URL: https://petrsu.ru/files/user/fdbd9903df09bb6f04f397450a13732b/Recom_Flu.pdf [Methodological recommendations for diagnostics and treatment and treatment of grippe. Ministry of Healthcare of Russian Federation. Moscow, 2016. URL: https://petrsu.ru/files/user/fdbd9903df09bb6f04f397450a13732b/Recom_Flu.pdf]
- Рекомендации Европейского регионального бюро ВОЗ по вакцинации против гриппа в зимний сезон 2016-2017 гг. URL: http://www.euro.who.int/ data/assets/pdf_file/0004/321844/recommendations-influenza-vaccination-2016-2017-winterseason-ru.pdf [Recommendations of the European regional WHO buro concerning vaccination against grippe in winter season of 2016- 2017. URL: http://www.euro.who.int/ data/assets/pdf_file/0004/321844/recommendations-influenza-vaccination- 2016-2017-winter-season-ru.pdf]
- Lin J.C., Nichol K.L. Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome. Arch. Intern. Med. 2001;161:441-6.
- Zbinden D., Manuel O. Influenza vaccination in immunocompromised patients: efficacy and safety. Immunotherapy. 2014;6(2):131-9.
- Remschmidt C., Wichmann O., Harder T. Influenza vaccination in HIV-infected individuals: systematic review and assessment of quality of evidence related to vaccine efficacy, effectiveness and safety. Vaccine. 2014;32(43):5585-92.
- The Australian immunization handbook. 10th ed. 2013:158.
- Ceravolo A., Orsi A., Parodi V. et al. Influenza vaccination in HIV-positive subjects: latest evidence and future perspective. J. Prev. Med. Hyg. 2013;54:1-10.
- Crum-Cianflone N.F., Wallace M.R. Vaccination in HIV-infected adults. AIDS Patient Care STDS. 2014;28(8):397-410.
- Crum-Cianflone N.F., Sullivan E. Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part I. Infect. Dis. Ther. 2017;6(3):303-31.
- Методы определения качества иммунобиологических препаратов для профилактики гриппа. Методические указания МУ 3.3.2.1758-03. - М., 2003. [Methods of determination of the quality of immunobiological medicaments for grippe prevention. Methodical guidelines of MU 3.3.2.1758-03. - М., 2003.]
- Concept Paper on the Revision of the CPMP/BWP Note for Guidance on Harmonization of Requirements for influenza Vaccines (CPMP/BWP/214/96). London, 31 May, 2001 / CPMP/EWP/1045/01.
Arquivos suplementares
